PartsTable
Technical Data Sheet
Download PDF

NDC00591-3543-76 — BUPROPION HYDROCHLORIDE TABLETS

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00591-3543-76: BUPROPION HYDROCHLORIDE TABLETS.

BUPROPION HYDROCHLORIDE TABLETS. Key specifications include administration: ORAL, coating_feature: FILM, NONENTERIC, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, supplementary_features: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET, primary_container_content_quantity: 60.000 TABLETS.

This part is cataloged in the U.S. Government catalog under NSN 6505-01-505-6640, indicating validated use in U.S. government and defense logistics supply chains.

Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00591-3543-76
NSN: 6505-01-505-6640
FSC: 6505 — Drugs and Biologicals
CAGE: 3V8D7 — TEVA PHARMACEUTICALS USA, INC. (USA)
SPECIFICATIONS
administrationORAL
coating_featureFILM, NONENTERIC
special_featuresTO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
long_action_methodEXTENDED RELEASE
primary_container_typeBOTTLE
supplementary_featuresADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
total_primary_container_quantity1
primary_container_content_quantity60.000 TABLETS
active_medicament_medicinal_strength150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyBUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
american_hospital_formulary_service_classification_number281604
NSN6505-01-505-6640
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available BUPROPION HYDROCHLORIDE TABLETS TITLE COMPONENT PN NDC00591-3543-76 MFR BUPROPION HYDROCHLORID
KEY FEATURES
•
LONG ACTION METHOD: EXTENDED RELEASE
•
ADMINISTRATION: ORAL
•
COATING FEATURE: FILM, NONENTERIC
•
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
•
SUPPLEMENTARY FEATURES: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
•
PRIMARY CONTAINER TYPE: BOTTLE
TECHNICAL CHARACTERISTICS
LONG ACTION METHODEXTENDED RELEASE
ADMINISTRATIONORAL
COATING FEATUREFILM, NONENTERIC
PRIMARY CONTAINER CONTENT QUANTITY60.000 TABLETS
SUPPLEMENTARY FEATURESADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
PRIMARY CONTAINER TYPEBOTTLE
SPECIAL FEATURESTO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
PART NAME ASSIGNED BY CONTROLLING AGENCYBUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER281604
ACTIVE MEDICAMENT MEDICINAL STRENGTH150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 1
03-0056Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00591-3543-76?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00591-3543-76?
NDC00591-3543-76 is a BUPROPION HYDROCHLORIDE TABLETS.
What parts can replace NDC00591-3543-76?
There is 1 known substitute for NDC00591-3543-76: 03-0056. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00591-3543-76?
NDC00591-3543-76 is cataloged in the U.S. Government catalog under NSN 6505-01-505-6640. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00591-3543-76